Patent details

Basic Information

Publication number:

EP1491201

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP040235574

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides

French Title of Invention:

Procédés de réduction de la toxicité de 5-fluorouracil avec des nucléosides pyrimidiniques acylés

German Title of Invention:

Methoden zur Reduktion der Toxizität von 5-Fluorouracil mittels acylierter Pyrimidinnukleoside

SPC Number:

Dates

Filing date:

06/06/1996

Grant date:

22/03/2006

EP Publication Date:

22/03/2006

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/12/2004

EP B1 Publication Date:

22/03/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/06/2016

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/06/1996

 

 

Name:

Wellstat Therapeutics Corporation

Address:

930 Clopper Road, Gaithersburg, MD 20878, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

22/03/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Vonborstel Reid W.

Address:

United States (US)

2

Name:

Bamat Michael K.

Address:

United States (US)

Priority

Priority Number:

472210

Priority Date:

07/06/1995

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/7068;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

26/11/2015

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

OFFICE FREYLINGER S.A.

Filing date	Document type	Number of pages